- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Raquibul Hannan, MD, PhD | Authors
‘Number of Unanswered Questions’ Remain About Role of Stereotactic Radiation in Metastatic Kidney Cancer
December 26, 2022
An expert from the University of Texas Southwestern Medical Center questions how providers are currently utilizing stereotactic radiation in the treatment of metastatic kidney cancer.
‘Interesting’ Research Continues to Assess the Role of Radiation in Management of Metastatic Kidney Cancer
December 21, 2022
Ongoing clinical trials are exploring the cytoreductive properties and immunogenic potential of stereotactic radiation in the treatment of patients with metastatic kidney cancer, according to an expert from the University of Texas Southwestern Medical Center.
SBRT Controls Metastatic Kidney Cancer ‘For As Much as 2 Years’, Says Expert
December 04, 2022
An expert from the University of Texas Southwestern Medical Center in Dallas describes the efficacy of stereotactic radiation in the treatment of patients with metastatic kidney cancer.
How SBRT Has Evolved Over the Decades to Manage Kidney Cancer
December 03, 2022
An expert from the University of Texas Southwestern Medical Center in Dallas gives an overview of the multimodal use of stereotactic radiation for the treatment of patients with metastatic kidney cancer.
Stereotactic Radiation Offers ‘Another Modality’ for the Management of Metastatic Kidney Cancer, Says Expert
December 02, 2022
An expert from the University of Texas Southwestern Medical Center in Dallas emphasized that stereotactic radiation provides oncologists with an alternative modality for treating patients with kidney cancer for whom standard ablative surgery is not an option.